Organon & Co. (NYSE:OGN – Get Free Report) has been given a consensus rating of “Hold” by the seven brokerages that are ...

Larson Financial Group LLC grew its holdings in Organon & Co. (NYSE:OGN – Free Report) by 345.4% in the fourth quarter, ...

In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

An acclaimed original graphic novel is making a welcome return thanks to Papercutz, and we’ve got your exclusive first look and details right here! Papercutz is pulling the curtain back on the ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Organon (OGN – Research Report), with a price target of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once ...

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Organon beat analysts’ revenue expectations by 1.1% last ...

JERSEY CITY, N.J., March 08, 2025--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced results from an analysis of the Phase 3 ADORING 3 open-label ...